Over the past week, companies developing artificial intelligence products for healthcare have announced a series of impressive fundraising rounds that set the tone for what could be a banner year for AI investments.
Timed for the JP Morgan Healthcare Conference, announcements include $275 million for Innovaccer, a healthcare data company with an increasing focus on AI, $141 million for Hippocratic AI, a company that develops generative AI agents to facilitate clinical tasks, and $105 million for Qventus, which offers automation and AI agents to facilitate surgical workflows. Qualified health And Collatetwo early-stage generative AI startups, targeting hospitals and the pharmaceutical sector respectively, have each announced $30 million in funding. Eli Lilly and Andreessen Horowitz announcement a new $500 million fund to bet on innovations, notably AI, and Andreessen too confirmed she led funding for Slingshot AI, a company developing a basic model for psychology.
Since OpenAI’s ChatGPT sparked a wave of excitement about the potential of AI, the technology has become a specific target for healthcare investors. According to the data published this week According to consultancy Rock Health, startups using AI accounted for 37% of digital health funding in 2024. Although overall investment in health tech companies is still declining, AI-focused startups are financed.
This article is reserved for STAT+ subscribers
Unlock this article – and get additional analysis of the technologies disrupting healthcare – by subscribing to STAT+.
Already have an account? Log in